At ThinkGenetic, Inc. our goal is to reduce the time to diagnosis for genetic and rare conditions. Given they are rare, we must be cognizant of the time it takes […]
[Press Release] Guardian Research Network and ThinkGenetic Announce Collaborative Partnership to Accelerate Diagnosis and Treatment Options for Patients with Genetic Diseases and Inherited Predisposition to Cancer
Guardian Research Network, Inc.® (GRN) and ThinkGenetic, Inc. announce a strategic collaboration to accelerate the diagnosis and support the development of treatment options for patients with rare and genetic diseases.
[VIDEO] New Study Results: Severity scoring system to identify patient risk for genetic conditions
Development and implementation of an automated severity scoring system to identify patients at possible increased risk for specific genetic conditions NSGC 2021 Poster UM353
Could a Biological Trojan Horse Help Us Cure Genetic Diseases?
Most medical treatments fall into four broad categories based on their goal: For the most part, treatments for genetic diseases have fallen into the preventive, disease management, or palliative categories. […]
ThinkGenetic Partners with Genome Medical
New Partnership Strengthens ThinkGenetic’s Continued Effort to Reduce Time to Diagnosis In an influential move for the genetics community, ThinkGenetic (ThinkGenetic.com) and Genome Medical (GenomeMedical.com), a nationwide specialty medical practice […]
